These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22491086)

  • 21. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
    Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country.
    Goetghebuer T; Smolen KK; Adler C; Das J; McBride T; Smits G; Lecomte S; Haelterman E; Barlow P; Piedra PA; van der Klis F; Kollmann TR; Lauffenburger DA; Alter G; Levy J; Marchant A
    Clin Infect Dis; 2019 Mar; 68(7):1193-1203. PubMed ID: 30215689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
    Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
    AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.
    Imam T; Jitratkosol MH; Soudeyns H; Sattha B; Gadawski I; Maan E; Forbes JC; Alimenti A; Lapointe N; Lamarre V; Money DM; Côté HC;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):495-502. PubMed ID: 22580562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic: A STROBE-compliant study.
    Mossoro-Kpinde CD; Gody JC; Mboumba Bouassa RS; Moussa S; Jenabian MA; Péré H; Charpentier C; Matta M; Longo JD; Grésenguet G; Djoba Siawaya JF; Bélec L
    Medicine (Baltimore); 2020 May; 99(21):e19978. PubMed ID: 32481261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
    Bae WH; Wester C; Smeaton LM; Shapiro RL; Lockman S; Onyait K; Thior I; Essex M
    AIDS; 2008 Aug; 22(13):1633-40. PubMed ID: 18670224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In utero exposure to antiretroviral therapy: feasibility of long-term follow-up.
    Hankin C; Lyall H; Willey B; Peckham C; Masters J; Tookey P
    AIDS Care; 2009 Jul; 21(7):809-16. PubMed ID: 19504373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
    Newell ML; Borja MC; Peckham C;
    Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Birth Prevalence of Congenital Cytomegalovirus Infection in HIV-Exposed Uninfected Children in the Era of Combination Antiretroviral Therapy.
    Purswani MU; Russell JS; Dietrich M; Malee K; Spector SA; Williams PL; Frederick T; Burchett S; Redmond S; Hoffman HJ; Torre P; Lee S; Rice ML; Yao TJ;
    J Pediatr; 2020 Jan; 216():82-87.e2. PubMed ID: 31668479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of antiretroviral drugs in pregnancy.
    Thorne C; Newell ML
    Expert Opin Drug Saf; 2005 Mar; 4(2):323-35. PubMed ID: 15794723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.
    Le Doaré K; Bland R; Newell ML
    Pediatrics; 2012 Nov; 130(5):e1326-44. PubMed ID: 23118140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
    Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.
    Knapp KM; Brogly SB; Muenz DG; Spiegel HM; Conway DH; Scott GB; Talbot JT; Shapiro DE; Read JS
    Pediatr Infect Dis J; 2012 Feb; 31(2):164-70. PubMed ID: 21983213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda.
    Aizire J; Sikorskii A; Ogwang LW; Kawalazira R; Mutebe A; Familiar-Lopez I; Mallewa M; Taha T; Boivin MJ; Fowler MG;
    AIDS; 2020 Feb; 34(2):215-225. PubMed ID: 31634154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
    Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.
    Paul ME; Chantry CJ; Read JS; Frederick MM; Lu M; Pitt J; Turpin DB; Cooper ER; Handelsman EL
    Pediatr Infect Dis J; 2005 Jan; 24(1):46-56. PubMed ID: 15665710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
    Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
    Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
    Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
    Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.